Delivery Order SPE2DB22D2005-SPE2DB24FJQJ4
Award Date
7/19/24
Potential Completion Date
7/22/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the pharmaceutical product Menveo, a meningococcal vaccine, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on a Firm Fixed Price basis, with a ceiling value of $14,834.94 and a completion date of February 2, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This federal contract award is for the delivery of Menveo, a meningococcal vaccine, to the Defense Logistics Agency (DLA) for a total ceiling value of $25,185.60. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Menveo vaccines. The award has a ceiling value of $11,580.84 and an ultimate completion date of September 6, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,763.08 for the supply of the MENVEO vaccine, a meningococcal conjugate vaccine. The award was issued by the Defense Logistics Agency (DLA), a defense agency responsible for providing supplies and services to the U.S. military. The contract has a firm fixed price pricing type and an ultimate completion date of April 7, 2023. This award is part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENVEO, a vaccine for the prevention of meningococcal disease. The contract has a ceiling value of $13,704.50 and a period of performance through July 30, 2024. It is a firm-fixed-price contract, and there is no set-aside designation. Amerisourcebergen, through its extensive supply chain network, will provide this critical vaccine...
This federal contract award, valued at $4,041.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Menveo, a meningococcal vaccine, under a Firm Fixed Price contract. The contract has an ultimate completion date of May 5, 2025 and is not set aside. Amerisourcebergen Drug Corp also holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,898.00 firm fixed-price delivery order is for the supply of Menveo, a vaccine used to prevent meningococcal disease. The award is not associated with a set-aside program and is not part of a larger contract vehicle. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Menveo A-C-Y-W kits, which are vaccines used to prevent meningococcal disease. The contract has a ceiling value of $3,242.82 and a period of performance through May 2, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $260,618.70 and covers the delivery of the vaccine product Menveo (meningococcal groups A, C, Y and W-135 diphtheria conjugate vaccine) in 0.5 mL vials. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 2, 2025. AmerisourceBergen Drug...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $16,084.50 firm fixed-price contract is for the supply of the Menveo vaccine, a meningococcal vaccine, with a completion date of September 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...